CALLICUTT JACK W (CIK 1266773) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy GALT (60,000 shares), Sell GALT (13,914 shares), Sell GALT (25,732 shares), Sell GALT (20,354 shares), Buy GALT (18,210 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 60,000 | $0 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 13,914 | $58,439 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 25,732 | $100,355 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 20,354 | $74,699 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 18,210 | $20,213 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 9,586 | $57,804 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 19,701 | $21,868 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 19,701 | $118,797 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 2,323 | $2,857 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 2,323 | $14,008 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 28,100 | $55,638 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 28,100 | $174,782 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 9,586 | $18,980 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 18,210 | $113,266 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 1,880 | $3,722 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 1,880 | $11,318 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 1,675 | $1,859 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 1,675 | $10,100 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 1,736 | $2,135 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 1,736 | $10,468 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 200 | $396 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 200 | $1,200 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 200 | $222 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Sell | 200 | $1,200 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | Buy | 200 | $344 |
Source: SEC Form 4 filings · as of 2026-01-06